I agree that this site is using cookies. You can find further informations here.
X
Chandwani, Sheenu
45  results:
Search for persons X
?
1

Real-World Data Quality Framework for Oncology Time to Trea..:

Ru, Boshu ; Sillah, Arthur ; Desai, Kaushal...
JMIR Medical Informatics.  12 (2024)  - p. e47744 , 2024
Link: https://doi.org/10.2196/..
 
?
2

Real-World Therapy with Pembrolizumab: Outcomes and Surroga..:

Mohr, Peter ; Scherrer, Emilie ; Assaf, Chalid...
Cancers.  14 (2022)  7 - p. 1804 , 2022
Link: https://doi.org/10.3390/..
 
?
3

Real-world effectiveness of pembrolizumab in advanced melan..:

Casarotto, Emilie ; Chandwani, Sheenu ; Mortier, Laurent...
Immunotherapy.  13 (2021)  11 - p. 905-916 , 2021
Link: https://doi.org/10.2217/..
 
?
4

Real-World Time on Treatment with Immuno-Oncology Therapy i..:

Ramakrishnan, Karthik ; Liu, Zhiwen ; Baxi, Shrujal...
Future Oncology.  17 (2021)  23 - p. 3037-3050 , 2021
Link: https://doi.org/10.2217/..
 
?
5

Pembrolizumab for Previously Treated, PD-L1–expressing Adva..:

Velcheti, Vamsidhar ; Chandwani, Sheenu ; Chen, Xin..
Clinical Lung Cancer.  21 (2020)  5 - p. e445-e455 , 2020
Link: https://doi.org/10.1016/..
 
?
6

Temporal phenotyping by mining healthcare data to derive li..:

Meng, Weilin ; Ou, Wanmei ; Chandwani, Sheenu...
Journal of Biomedical Informatics.  100 (2019)  - p. 103335 , 2019
Link: https://doi.org/10.1016/..
 
?
7

Cost Effectiveness of PD-L1-Based Test-and-Treat Strategy w..:

Loong, Herbert H. ; Wong, Carlos K. H. ; Leung, Linda Kam Suet...
PharmacoEconomics - Open.  4 (2019)  2 - p. 235-247 , 2019
Link: https://doi.org/10.1007/..
 
?
8

Outcomes of First-Line Pembrolizumab Monotherapy for PD-L1-..:

Velcheti, Vamsidhar ; Chandwani, Sheenu ; Chen, Xin...
Immunotherapy.  11 (2019)  18 - p. 1541-1554 , 2019
Link: https://doi.org/10.2217/..
 
?
9

First-Line Pembrolizumab Monotherapy for Metastatic Pd-L1-P..:

Velcheti, Vamsidhar ; Chandwani, Sheenu ; Chen, Xin..
Immunotherapy.  11 (2019)  10 - p. 889-901 , 2019
Link: https://doi.org/10.2217/..
 
?
10

Q-TWiST Analysis to Assess Benefit–Risk of Pembrolizumab in..:

Huang, Min ; Pietanza, M. Catherine ; Samkari, Ayman...
PharmacoEconomics.  37 (2018)  1 - p. 105-116 , 2018
Link: https://doi.org/10.1007/..
 
?
11

Chronic Conditions, Medical Out‐of‐Pocket Expenditure Burde..:

Anong, Sophia T. ; Ajongwen, Patience ; Chandwani, Sheenu
Family and Consumer Sciences Research Journal.  45 (2016)  2 - p. 150-165 , 2016
Link: https://doi.org/10.1111/..
 
?
12

Associations between sociodemographic and clinicopathologic..:

Llanos, Adana A. M. ; Chandwani, Sheenu ; Bandera, Elisa V....
Cancer Causes & Control.  26 (2015)  12 - p. 1737-1750 , 2015
Link: http://www.jstor.org/sta..
 
?
13

Adverse Outcomes Among Asian Indian Singleton Births in New..:

Kurtyka, Karen ; Gaur, Sunanda ; Mehrotra, Naveen...
Journal of Immigrant and Minority Health.  17 (2015)  4 - p. 1138-1145 , 2015
Link: https://www.jstor.org/st..
 
?
14

Associations between sociodemographic and clinicopathologic..:

Llanos, Adana A. M. ; Chandwani, Sheenu ; Bandera, Elisa V....
Cancer Causes & Control.  26 (2015)  12 - p. 1737-1750 , 2015
Link: https://doi.org/10.1007/..
 
?
15

Role of Preoperative Magnetic Resonance Imaging in the Surg..:

Chandwani, Sheenu ; George, Prethibha A. ; Azu, Michelle...
Annals of Surgical Oncology.  21 (2014)  11 - p. 3473-3480 , 2014
Link: https://doi.org/10.1245/..
 
1-15